Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach
The American Journal of Gastroenterology Supplements · 2014
DOI: 10.1038/ajgsup.2014.7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of Gastroenterology Supplements, 2014. Verfasst von Spencer Dorn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
- Nevada Veteran's Affairs Medical Center, Las Vegas, Nevada, USA.
Zitieren
APA
Dorn, S., Lembo, A., & Cremonini, F. (2014). Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach. The American Journal of Gastroenterology Supplements. https://doi.org/10.1038/ajgsup.2014.7
Vancouver
Dorn S, Lembo A, Cremonini F. Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach. The American Journal of Gastroenterology Supplements. 2014. doi:10.1038/ajgsup.2014.7
BibTeX
@article{Dorn2014,
author = {Dorn, Spencer and Lembo, Anthony and Cremonini, Filippo},
title = {Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach},
journal = {The American Journal of Gastroenterology Supplements},
year = {2014},
doi = {10.1038/ajgsup.2014.7}
}
EUVIMED